Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma

Fig. 2

Serum levels of CXC motif chemokine 10 (CXCL10) (A, C), squamous cell carcinoma antigen (SCC-Ag) (B) in patients with cervical squamous cell carcinoma and control subjects. There are five groups: healthy controls (Healthy), patients with cervical intraepithelial neoplasia (CIN), patients with cervical squamous cell carcinoma (CESC), CESC early stage, and CESC late stage

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us